Systems and methods to restore perfusion to a vessel

US12076037B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12076037-B2
Application numberUS-202318232449-A
CountryUS
Kind codeB2
Filing dateAug 10, 2023
Priority dateMar 9, 2011
Publication dateSep 3, 2024
Grant dateSep 3, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and systems for using a clot retrieval device for treating a clot in a blood vessel for use in the treatment of ischemic stroke to achieve a clinically effective revascularization or perfusion rate for clots comprising a higher ratio of red blood cells to fibrin.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of restoring blood flow in neurovasculature by removing thrombus in human patients experiencing ischemic stroke, the method comprising: delivering a dual-layer clot retrieval device to a blood vessel of a respective human patient of a plurality of human patients for retrieving a clot; passing the dual layer clot retrieval device by, through, or about the clot in two passes or less; and removing the dual layer clot retrieval device after two passes or less, to improve a final revascularization rate under a modified treatment in cerebral infarction score (mTICI) for approximately 42% of the human patients in the plurality of human patients. 2. The method of claim 1 , further comprising achieving a good clinical outcome of mRS from approximately 71.1% to approximately 81.3% under a modified Rankin Scale (mRS) score of 0-2 within a predetermined time period comprising 90-days following restoring perfusion to the blood vessel. 3. The method of claim 1 , further comprising achieving a reduced clot fracturing after two passes of the dual layer clot retrieval device by, through, or about the clot. 4. The method of claim 1 , further comprising achieving approximately an 80% final revascularization rate mTICI greater than 2b after two passes of the dual layer clot retrieval device by, through, or about the clot. 5. The method of claim 4 , wherein further comprising restoring perfusion to the blood vessel after a single pass of the dual layer clot retrieval device by, through, or about the clot and removing the dual layer clot retrieval device to achieve a final revascularization rate mTICI≥2c-3 in approximately 80% of human patients in the plurality of human patients. 6. The method of claim 1 , wherein the clot is located in one of the following locations: a carotid artery, a MI middle cerebral artery, a M2 middle cerebral artery, a basilar artery, and a vertebral artery. 7. The method of claim 1 , wherein the dual-layer clot retrieval device comprises: a first framework of struts forming a tubular main body portion; and a second framework of struts forming an outer tubular body at least partially surrounding the tubular main body portion, wherein the outer tubular body is expandable to a radial extent to define a clot reception space. 8. The method of claim 7 , wherein the tubular main body portion further comprises a porous inner body, and the outer tubular body comprises a plurality of longitudinally spaced clot scaffolding segments comprising closed cells whereby each of the plurality of longitudinally spaced clot scaffolding segment is separated by a clot inlet mouth and at least one closed cell of each of the plurality of longitudinally spaced clot scaffolding segment terminates in a distal apex free from connection to an adjacent closed cell.

Assignees

Inventors

Classifications

  • Dilators made of swellable material {(balloon catheters for angioplasty A61M25/104)} · CPC title

  • Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting · CPC title

  • having an open distal end · CPC title

  • Dilators with or without means for introducing media, e.g. remedies · CPC title

  • having a closed distal end, e.g. a loop · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12076037B2 cover?
Methods and systems for using a clot retrieval device for treating a clot in a blood vessel for use in the treatment of ischemic stroke to achieve a clinically effective revascularization or perfusion rate for clots comprising a higher ratio of red blood cells to fibrin.
Who is the assignee on this patent?
Neuravi Ltd
What technology area does this patent fall under?
Primary CPC classification A61B17/221. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).